No abstract

In this cohort of nearly 15000 11-year-old girls with insurance (commercial or Medicaid), the human papillomavirus vaccine was administered at only 1 in 4 well-adolescent visits and approximately one-third of vaccine-related visits, which suggests a substantial number of missed opportunities.

No abstract

Disparities continue to exist in the timely provision of postpartum contraception. This study aimed to identify prevalence and factors associated with postpartum contraception provision among women enrolled in Medicaid. A retrospective cohort study was conducted using the 2014 National Medicaid data, linked to county-level social vulnerability index (SVI) data. Women aged 15–44 with a live birth in 2014 were included. Multivariable logistic regression was used to predict 3-day provision of long-acting reversible contraception (LARC) and 60-day provision of most effective or moderately effective contraceptives (MMEC). Overall, 3-day LARC provision was 0.2% while 60-day MMEC was 36.3%. Significantly lower odds of receiving MMEC was found among women aged 15–20 (adjusted odds ratio[aOR] = 0.87; 95% CI:0.86–0.89) compared to women 20–44 years as well as among Asian women (aOR = 0.69; 95% CI:0.66–0.72) and Hispanic women (aOR = 0.73; 95% CI:0.72–0.75) compared to White women. The provision of postpartum contraception remains low, generally, and needs attention in communities experiencing poor maternal outcomes.

and having previous diabetes-related hospitalizations increased the likelihood of insulin adherence alone. Higher insulin treatment persistence and adherence were also associated with lower hemoglobin A1c at follow-up, lower healthcare utilization, and higher pharmacy costs. Only insulin persistence was associated with lower total healthcare costs and a greater reduction in A1C from baseline. ConCluSionS: Treatment adherence/persistence among patients with T2DM initiating basal insulin are influenced by numerous factors. Greater insulin adherence/persistence is linked to improved clinical outcomes and reduced healthcare utilization. Such methodologies may be suitable for an insulin quality performance measure.